| editorial | Q871232 |
| scholarly article | Q13442814 |
| P50 | author | Allan D. Struthers | Q37841538 |
| Chim C. Lang | Q41297830 | ||
| P2093 | author name string | Maheshwar Pauriah | |
| P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
| Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors | Q24803555 | ||
| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 | ||
| Simvastatin with or without ezetimibe in familial hypercholesterolemia | Q28274454 | ||
| Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
| Surrogate endpoints: a basis for a rational approach | Q35488355 | ||
| Hormone replacement therapy: prothrombotic vs. protective effects | Q35543674 | ||
| Endothelial function: a critical determinant in atherosclerosis? | Q35789874 | ||
| Advancement of biomarker discovery and validation through the HUPO plasma proteome project | Q42870408 | ||
| Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction | Q43746731 | ||
| Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy | Q44522432 | ||
| Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus | Q44786820 | ||
| C-reactive protein levels and outcomes after statin therapy | Q45213511 | ||
| Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease | Q45213515 | ||
| Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers | Q46588893 | ||
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 85-88 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Cardiovascular Therapeutics | Q1871490 |
| P1476 | title | Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study | |
| P478 | volume | 26 |
| Q35440499 | Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters |
| Q51310417 | Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study. |
Search more.